Current Pharmaceutical Biotechnology
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 11
Author(s): Giandomenico Roviello
Affiliation:
Export Options
About this article
Cite this article as:
Roviello Giandomenico , Meet Our Editorial Board Member, Current Pharmaceutical Biotechnology 2018; 19 (11) . https://dx.doi.org/10.2174/138920101911181130150143
DOI https://dx.doi.org/10.2174/138920101911181130150143 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
18
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gastrin-Releasing Peptide Receptor as a Molecular Target for Psychiatric and Neurological Disorders
CNS & Neurological Disorders - Drug Targets Targeting Phospholipase D-mediated Survival Signals in Cancer
Current Signal Transduction Therapy Topical Dermatological Drug Delivery: Quo Vadis?
Current Drug Delivery Surface Markers of Cancer Stem Cells in Solid Tumors
Current Stem Cell Research & Therapy Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Microaspiration in Intubated Critically Ill Patients: Diagnosis and Prevention
Infectious Disorders - Drug Targets Metals and Metal Derivatives in Medicine
Mini-Reviews in Medicinal Chemistry COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) From Peptides to Small Molecules: An Intriguing but Intricated Way to New Drugs
Current Medicinal Chemistry Functional Properties of Pentacyclic Triterpenes Contained in "Orujo" Olive Oil
Current Nutrition & Food Science Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism
Current Nutrition & Food Science PDGF/PDGFR Signaling and Targeting in Cancer Growth and Progression: Focus on Tumor Microenvironment and Cancer-associated Fibroblasts
Current Pharmaceutical Design Antioxidative Peptides: Trends and Perspectives for Future Research
Current Medicinal Chemistry Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways
Current Drug Metabolism Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Current Clinical Pharmacology Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery The Curcumin Analog EF24 is Highly Active Against Chemotherapy- Resistant Melanoma Cells
Current Cancer Drug Targets <i>Helicobacter Pylori</i> Interacts with Serum Vitamin D to Influence Hypertension
Current Aging Science